Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Scotland's public finances from Goschen to Barnett

McCrone, Gavin (1999) Scotland's public finances from Goschen to Barnett. Quarterly Economic Commentary, 24 (2). pp. 30-46. ISSN 0306-7866

[img]
Preview
Text (FEC_24_2_1999_McCroneG)
FEC_24_2_1999_McCroneG.pdf
Final Published Version

Download (1MB) | Preview

Abstract

As this paper is being written, the election of the Scottish ParUament is only a matter of weeks away, yet there still appears to be a poor understanding, not only in the public mind, but probably in that of many politicians that hope to be elected, of how Scotland's public finances will operate. The White paper says that 'Scotland will continue to benefit from an appropriate share of United Kingdom public expenditure' and that the present block arrangements will remain in place adjusted annually by the Bamett formula.1 This is usually taken to mean that expenditure will continue to be based on need. But how does the formula work and has it resulted in a provision of expenditure based on need? Will it do so in the future?